CV Advisors Invests Heavily in Merck & Co., Inc.

CV Advisors LLC, a financial firm, has made a significant investment in Merck & Co., Inc. (NYSE:MRK), acquiring 10,000 shares of the company's stock valued at approximately $1,285,000 in the second quarter.

This is not an isolated instance, as several other hedge funds have also increased their stakes in Merck & Co., Inc. over the past few quarters.

Wellington Management Group LLP, for example, boosted its position by 14.8% in the fourth quarter, while Cardano Risk Management B.V. acquired a new stake worth about $1,012,530,000 during the same period.